Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
Sales | 417 | 380 | 3,478 | 599 | 450 |
Gross Profit | 417 | 380 | 3,478 | 599 | 450 |
Operating Expenses | 6,581 | 7,199 | 5,885 | 6,028 | 6,681 |
Operating Income | -6,164 | -6,819 | -2,407 | -5,429 | -6,231 |
Other Income | 41 | 9 | 5 | 10 | 13 |
Pre-tax Income | -6,123 | -6,810 | -2,402 | -5,419 | -6,218 |
Net Income Continuous | -6,123 | -6,810 | -2,402 | -5,419 | -6,218 |
Net Income | $-6,123 | $-6,810 | $-2,402 | $-5,419 | $-6,218 |
EPS Basic Total Ops | -0.08 | -0.12 | -0.04 | -0.10 | -0.12 |
EPS Basic Continuous Ops | -0.08 | -0.11 | -0.04 | -0.10 | -0.12 |
EPS Diluted Total Ops | -0.08 | -0.12 | -0.04 | -0.10 | -0.12 |
EPS Diluted Continuous Ops | -0.08 | -0.11 | -0.04 | -0.10 | -0.12 |
EBITDA(a) | $-6,007 | $-6,770 | $-2,324 | $-5,506 | $-6,310 |